CATEGORY

Academic Research

R&D collaboration in the discovery phase that accelerates innovation.

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Academic Research.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Academic Research Industry Benchmarks


Savings Achieved

(in %)

The average annual savings achieved in Academic Research category is 2.90%

Payment Terms

(in days)

The industry average payment terms in Academic Research category for the current quarter is 101.3 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length

SLAs/KPIs

Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk

Sanctions

AMEs

Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Academic Research Suppliers


    10,685
    Total Suppliers
    534
    Diverse Suppliers
    73
    Normalized Supplier Rating
    Academic Research Supplier

    Find the right-fit academic research supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    IQVIA HOLDINGS INC.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    4
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    36

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    41
    Social
    30
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    48
    Human rights
    39
    Community Environment
    31
    Corporate governance
    40
    Human resources
    22
    Security Scorecard
    77

    Threat indicators
    C
    75
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    D
    63
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    C
    70
    Application Security
    Detecting common website application vulnerbilities
    C
    77
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    D
    60
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    100
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    iqvia.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    1
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    1
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    2
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    2
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    28
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    Academic Research market report transcript


    Global Market Outlook on Academic Research

    • The global ARO market is around $215–230 million and is experiencing a growth rate of 8–10 percent.
    • The failure rate of drugs especially in therapeutic areas has increased to an extent that there will be a greater reliance on academic engagements by the pharmaceutical players
    • The market size is indicative of the total revenue earned through pharmaceutical players through various contracts and does not include the grants

     

    Cost & Pricing Analysis

    Clinical Trial Cost Structure

    • The major cost of investment lies in site monitoring and management, and data management, statistics, regulatory & QA
    • Complexity and duration of the trial are the major cost drivers
    • Various parameters like the number and location of the sites, patient recruitment (number of patients to be recruited), timelines are determined by the above mentioned parameters

    Principal Investigator Salary

    • The average hourly wage of a Principal Investigator ranges from 60–70 $/hour
    • Certain organizations like NIH pays around $70/hour
    • Network of the investigator and relevant experience are the factors determining the salary

    Academic Research: Drivers and Constraints

    Drivers

    Failure Rate of Drugs:

    • The failure rate of drugs has increased dramatically over the years and thus an Increase in the drug development cost. Currently, only 0.4 drugs get developed per billion dollar spending. By extrapolating the current trend, hardly any drugs will be produced per billion dollar spending by 2023

    Requirement of technical/therapeutic area expertise

    • The subject matter expertise provided by the therapeutic area experts is unmatched in various areas. Therefore, the analysis provided by the academia experts and thus the pharmaceutical players have to engage the academia, either for the execution of the entire clinical trial or for specific functions like analysis, regulatory, etc.

    Adoption of Open Sourcing/Innovation models among the pharmaceutical players

    • There is an increased adoption of open sourcing/innovations among the pharmaceutical players, by engaging various CROs, academia and peer pharma

    Constraints

    Increased lead time of the engagements and also the process

    • Increased lead time of the academia in conducting the clinical trials may decrease the demand/adoption of hybrid trials (both CRO and academia are engaged)